Sort
30,917 grants matching “tumor microenvironment”
Regulation and interplay of Heat Shock Factors in growth-associated proteotoxic stresses
$328,355Marc Mendillo · Northwestern University At Chicago · R01 · FY2022 · GM
Regulation and interplay of Heat Shock Factors in growth-associated proteotoxic stresses
$328,355Marc Mendillo · Northwestern University At Chicago · R01 · FY2025 · GM
Regulation and interplay of Heat Shock Factors in growth-associated proteotoxic stresses
$328,355Marc Mendillo · Northwestern University At Chicago · R01 · FY2023 · GM
Training of Surgeon Scientists in Basic and Translational Cancer Research
$328,346Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · T32 · FY2022 · CA
Biospecimen Repository and Pathology Core
$328,255George Plitas · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Project 1: Mechanisms of Stiffening in Liver Cancer
$328,252Dennis E. Discher · University Of Pennsylvania · U54 · FY2015 · CA
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$328,217John H Sampson · Duke University · P50 · FY2014 · CA
Role of Hypoxia-Induced miR-210 in Tumor Metabolism
$328,190Mircea Ivan · Indiana University Indianapolis · R01 · FY2014 · CA
Targeting eEF2 with the protein translation elongation inhibitor SVC112 in head and neck squamous cancer
$328,151Antonio Jimeno · University Of Colorado Denver · P50 · FY2023 · CA
Targeting eEF2 with the protein translation elongation inhibitor SVC112 in head and neck squamous cancer
$328,151Antonio Jimeno · University Of Colorado Denver · P50 · FY2022 · CA
Enhancing the Potency and Durability of Immunotherapies
$328,134Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Targeting the Pro-tumorigenic Microenvironment
$328,134Yves A Declerck · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Clinical Trials and Translation
$328,134Katherine Kurshan Matthay · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Exploiting Therapeutic Vulnerabilities
$328,133William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Hypoxia-activated probiotic agents for breast cancer
$328,114Tohru Yamada · University Of Illinois At Chicago · R01 · FY2025 · CA
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.
$328,110Xiao-Jing Wang · University Of Colorado Denver · P50 · FY2023 · CA
Treating recurrent HNSCC with radiation and dual TGF-Beta/PD-L1.
$328,109Xiao-Jing Wang · University Of Colorado Denver · P50 · FY2022 · CA
Role of HSP70 in Pancreatic Diseases
$328,106Ashok K Saluja · University Of Miami School Of Medicine · R01 · FY2018 · CA
Role of HSP70 in Pancreatic Diseases
$328,106Sundaram Ramakrishnan · University Of Miami School Of Medicine · R01 · FY2021 · CA
Genetic Analysis of Myeloproliferative Disease
$328,106John K Cowell · Augusta University · R01 · FY2020 · CA
MicroRNAs and chromosome 22q in the colon
$328,027Anil K Rustgi · University Of Pennsylvania · R01 · FY2012 · DK
MicroRNAs and chromosome 22q in the colon
$328,027Anil K Rustgi · University Of Pennsylvania · R01 · FY2011 · DK
Project 4
$327,992Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2023 · CA
3D-Adhesion Stromagenesis in Cancer Permissiveness
$327,986Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2014 · CA
Regulatory Immune Cell Networks in Cancer
$327,863Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2013 · CA